What Alberta Stroke Programme Early Computed Tomography Score (ASPECTS) would preclude thrombolysis with alteplase (tissue plasminogen activator) in a patient with acute ischemic stroke outside the 4.5 hour window?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ASPECTS Threshold for Thrombolysis Outside the 4.5-Hour Window

An ASPECTS score <6 should generally preclude thrombolysis with alteplase outside the 4.5-hour window, as lower scores are associated with increased risk of intracranial hemorrhage and poor functional outcomes without clear benefit. 1, 2

Evidence-Based Threshold

The most robust guideline evidence establishes ASPECTS ≥6 as a requirement for extended window treatment:

  • The 2015 AHA/ASA guidelines explicitly require ASPECTS ≥6 for endovascular therapy within 6 hours, and this threshold has been adopted for patient selection in extended window thrombolysis protocols 1
  • Current guidelines recommend ASPECTS ≥6 when considering alteplase beyond 4.5 hours with perfusion imaging selection 2, 3
  • The 2020 JACC guidelines note that even patients with ASPECTS <6 can benefit from endovascular thrombectomy, but this does not extend to thrombolysis alone, where hemorrhage risk is the primary concern 1

Supporting Research Evidence

Recent high-quality trials provide critical context:

  • The 2023 study on low ASPECTS patients (≤5) found that bridging thrombolysis was associated with very poor functional outcomes (OR 2.22) and significantly increased symptomatic intracranial hemorrhage (17.8% vs 6.4% for direct thrombectomy, OR 3.44) 4
  • The 2025 HOPE trial, which demonstrated benefit of alteplase at 4.5-24 hours, required salvageable brain tissue on perfusion imaging, implicitly excluding patients with extensive early ischemic changes 5
  • The 2025 EXPECTS trial for posterior circulation strokes specifically excluded patients with "extensive early hypodensity on computed tomography" 6

Practical Algorithm for Extended Window Decision-Making

When considering thrombolysis outside 4.5 hours:

  1. Calculate ASPECTS score on baseline non-contrast CT - scores range from 0-10, with 1 point subtracted for each region showing early ischemic changes 1, 2

  2. If ASPECTS <6: Do not proceed with thrombolysis - the hemorrhage risk outweighs potential benefit, particularly in the extended window 4, 2

  3. If ASPECTS ≥6: Proceed with advanced imaging (CT or MRI perfusion) to confirm salvageable tissue and core/perfusion mismatch 2, 3, 5

  4. Confirm no large vessel occlusion requiring thrombectomy - if LVO is present, proceed directly to mechanical thrombectomy rather than thrombolysis 3

Critical Caveats

Within the standard 3-hour window, the ASPECTS threshold is less stringent - the 2007 Stroke guidelines note that early ischemic changes >1/3 MCA territory were not independently associated with adverse outcomes when treatment occurred within 3 hours 1. However, this permissiveness does not extend beyond 4.5 hours.

For posterior circulation strokes, use the pc-ASPECTS (posterior circulation ASPECTS) - the 2024 ESO/ESMINT guidelines suggest pc-ASPECTS ≥8 for basilar artery occlusion treatment, though this is based on observational data 1

The relationship between ASPECTS and outcome is continuous - while ASPECTS ≥6 is the established threshold, lower scores within the 6-10 range still confer progressively better outcomes 7. An ASPECTS of 6 is the minimum acceptable, not the ideal.

Hemorrhage risk increases substantially with lower ASPECTS - the symptomatic intracranial hemorrhage rate in low ASPECTS patients receiving thrombolysis approaches 17-18%, compared to 2-4% in typical populations 4, 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Guidelines for Thrombolysis and Thrombectomy in Acute Ischemic Stroke Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

IV Thrombolysis Beyond 4.5 Hours in Acute Ischemic Stroke

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Alteplase for Posterior Circulation Ischemic Stroke at 4.5 to 24 Hours.

The New England journal of medicine, 2025

Research

Intravenous alteplase for Chinese patients with stroke and borderline eligibility.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2012

Research

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

The New England journal of medicine, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.